Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: Current status and challenges

Journal of Cancer

Volumn 5, Issue 4, 2014, Pages 262-271

  Young, Patrick E ^a,c   Womeldorph, Craig M ^b,c   Johnson, Eric K ^d   Maykel, Justin A ^e   Brucher, Bjorn ^f   Stojadinovic, Alex ^f   Avital, Itzhak ^f   Nissan, Aviram ^g   Steele, Scott R ^d  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d Madigan Army Hospital   (United States)

^e UMASS MEMORIAL MEDICAL CENTER   (United States)

^f Virginia Health System   (United States)

^g HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

CEA; colonoscopy; colorectal cancer; EUS; recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CONTRAST MEDIUM;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SURVEILLANCE; DISTANT METASTASIS; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; HUMAN; LYMPH VESSEL METASTASIS; MEDICATION COMPLIANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84896929549     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.7988     Document Type: Review

References (101)

1. American Cancer Society. Colorectal Cancer Facts & Figures 2011-2013. Atlanta: American Cancer Society, 2011.
2. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society task force on colorectal cancer. Gastroenterology 2006;130:1865-1871.
3. Desch, CE, Benson AB, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Scoiety of Clinical Oncology Practice Guideline. J Clin Oncol 2005;23:8512-8519
4. Scholl HJ, VanCutsem E, Stein A, et al. ESMO Consensus guidelines fo rthe management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 2012;23:2479-2516.
5. Poston GJ, Tait D, Oconnell S, et al. Diagnosis andmangement of colorectal cancer: summary of NICE guideance. BMJ 2011;343:1-4.
6. NCCN. NCCN Clinical Practice guidelines in oncology: Colon cancer; version 32013.
7. Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 2004; 47: 807-17.
8. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995;130:1062-1067.
9. Schwarz RE, Berlin JD, Lenz HJ, Nordlinger B, Rubbia-Brandt L, Choti MA. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB (Oxford) 2013;15(2):106-15.
10. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg K. Follow-Up After Curative Surgery For Colorectal Carcinoma. Dis Colon Rectum 1995; 38: 619-626.
11. Makela JT, Seppo OL, Kairaluoma MI. Five-Year Follow-Up After Radical Surgery For Colorectal Cancer. Arch Surg 1995; 130: 1062-1067.
12. Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A Prospective Randomized Study Of Follow-Up After Radical Surgery For Colorectal Cancer. Br J Surg 1997; 84: 666-660.
13. Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scan J Gastroenterol 1999; 34: 505-15.
14. Shoemaker D, Black R, Giles L, Toouli J. Yearly Colonoscopy, Liver CT, And Chest Radiography Do Not Influence 5-Year Survival Of Colorectal Cancer Patients. Gastroenterol 1998; 114: 7-14.
15. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role Of Follow-Up In Management Of Local Recurrences Of Colorectal Cancer. Dis Colon Rectum 1998; 41: 1127-1133.
16. Secco GB, Fardelli R, Gianquinto D, et al. Efficacy And Cost Of Risk Adapted Follow-Up In Patients After Colorectal Cancer Surgery: A Prospective, Randomized And Controlled Trial. Europ J Surg Oncol 2002; 28: 418-423.
17. Wattchow DA, Weller DP, Esterman A, et al. General Practice vs. Follow-Up For Patients With Colon Cancer: Randomized Controlled Trial. Br J Cancer 2006; 94: 1116-1121.
18. Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative Surveillance In Patients With Colorectal Cancer Who Have Undergone Curative Resection: A Prospective, Multicenter, Randomized, Controlled Trial. J Clin Oncol 2006; 24: 386-393.
19. Bruinvels DJ, Stiggelbout AM, Kievit J, et al. Follow-Up Of Patients With Colorectal Cancer. A Meta-Analysis. Ann Surg 1994; 219: 174-82.
20. Rosen M, Chan L, Beart RW, Vukasin P, Anthone G. Follow-Up Of Colorectal Cancer: A Meta-Analysis. Dis Colon Rectum 1998; 41: 1116-26.
21. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database of Syst Rev 2002; 1:CD002200. DOI: 10.1002/14651858.CD002200.
22. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact On Survival Of Intensive Follow-Up After Curative Resection For Colorectal Cancer: Systematic Review And Meta-Analysis Of Randomised Trials. BMJ 2002;324:813-6.
23. Figueredo A, Rumble RB, Maroun J, et al. and The Members Of The Gastrointestinal Cancer Disease Site Group Of Cancer Care Ontario's Program In Evidence-Based Care. Follow-Up Of Patients With Curatively Resected Colorectal Cancer: A Practice Guideline. BMC Cancer 2003; 3: 26.
24. Tjandra JJ, Chan MKY. Follow-Up After Curative Resection Of Colorectal Cancer: A Meta-Analysis. Dis Colon Rectum 2007, 50:1783-1799.
25. Jeffery M, Hickey BE, Hider PN. Follow-Up Strategies For Patients Treated For Non-Metastatic Colorectal Cancer. Cochrane Database Syst Rev 2008;1: Cd002200.Doi:10.1002/14651858.Cd002200.Pub2, 2002
26. Cortet M, Grimault A, Cheynel N, Lepage C, Bouvier A, Faivre J. Patterns of recurrence of obstructing colon cancers after surgery for cure: a population-based study. Colorectal Dis. 2013; doi: 10.1111/codi.12268.
27. Paty PB, Nash GM, Baron P, et al. Long-term results of local excision for rectal cancer. Ann Surg 2002; 236: 522-29.
28. Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum 2000; 43:1064-71.
29. You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg 2007; 245:726-33.
30. Sengupta S, Tjandra JJ: Local excision of rectal cancer: what is the evidence? Dis Colon Rectum 2000; 44:1345-61.
31. Bouvet M, Milas M, Giacco GG, Cleary KR, Janjan NA, Skibber JM. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol 1999; 6:26-32.
32. Nissan A, Stojadinovic A, Shia J, et al. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 2006; 24:4078-84.
33. Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Telenta MT. Rectal cancer: local recurrence after surgery without radiotherapy. Dis Colon Rectum 2001; 44:374-9.
34. Peparini N, Maturo A, Di Matteo FM, Mele R, Benedetti F, Di Matteo G. Long-term survival and recurrences after total nerve-sparing surgery for rectal cancer. Hepatogastroenterology 2006; 53:850-3.
35. Richardson DP, Porter GA, Johnson PM. Surgeon knowledge contributes to the relationship between surgeon volume and patient outcomes in rectal cancer. Ann Surg 2013; 257(2):295-301.
36. Kusters M, Marijnen CA, van de Velde CJ, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010; 36(5):470-6.
37. Fichera A, Allaix ME. Paradigm-Shifting New Evidence for Treatment of Rectal Cancer. J Gastrointest Surg. 2013; [Epub ahead of print]
38. Marks G, Mohiuddin MM, Masoni L, Pecchioli L. High-dose preoperative radiation and full-thickness local excision. A new option for patients with select cancers of the rectum. Dis Colon Rectum 1999; 33:735-9.
39. Russell AH, Harris J, Rosenberg PJ, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys 2000; 46:313-22.
40. Mohiuddin M, Marks G, Bannon J. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers. Int J Radiat Oncol Biol Phys 1994; 30(4):845-9.
41. Perez RO, Habr-Gama A, Proscurshim I, et al. Local excision for ypT2 rectal cancer--much ado about something. J Gastrointest Surg 2007; 11:1431-8.
42. Perez RO, Habr-Gama A, Lynn PB, et al. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Dis Colon Rectum 2013; 56(1):6-13.
43. Pema PJ, Bennett WF, Bova JG, Warman P. CT vs MRI in diagnosis of recurrent rectosigmoid carcinoma. J Comput Assist Tomogr 1994;18(2):256-61.
44. Walter CJ, Al-Allak A, Borley N, et al. Fifth-year surveillance computed tomography scanning after potentially curative resections for colorectal cancer. Surgeon 2013;11:25-29.
45. Schaefer O, Langer M. Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 2007; 17(8):2044-54.
46. Blomqvist L, Ohlsén H, Hindmarsh T, Jonsson E, Holm T. Local recurrence of rectal cancer: MR imaging before and after oral superparamagnetic particles vs contrast-enhanced computed tomography. Eur Radiol. 2000;10(9):1383-9.
47. Bipat S, van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. Radiology 2005;237(1):123-131.
48. Titu LV, Nicholson AA, Hartley JE, Breen DJ, Monson JR. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Ann Surg 2006; 243(3):348-352.
49. Chew MH, Brown WE, Masya L, Harrison JD, Myers E, Solomon MJ. Clinical, MRI, and PET-CT criteria used by surgeons to determine suitability for pelvic exenteration surgery for recurrent rectal cancers: a Delphi study. Dis Colon Rectum 2013; 56(6):717-25.
50. Schmidt GP, Baur-Melnyk A, Haug A, et al. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 2009; 19(6):1366-78.
51. Votrubova J, Belohlavek O, Jaruskova M, et al. The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2006; 33:779-784.
52. Kishimoto G, Mrakami K, Con SA, et al. Follow-up after curative resection for colorectal cancer: impact of positron emission tomography-computed tomography (PET/CT). Rev Gastroenterol Peru 2010; 30(4):328-33.
53. Fukunaga H, Sekimoto M, Ikeda M, et al. Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer. Ann Surg Oncol 2005; 12(7):561-9.
54. Giacomobono S, Gallicchio R, Capacchione D, et al. F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer. Int J Colorectal Dis. 2013; [Epub ahead of print]
55. Peng NJ, Hu C, King TM, Chiu YL, Wang JH, Liu RS. Detection of resectable recurrences in colorectal cancer patients with 2-[(18)f]fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography. Cancer Biother Radiopharm 2013; 28(6):479-87.
56. Fiocchi F, Iotti V, Ligabue G, et al. Contrast-enhanced MRI and PET-CT in the evaluation of patients with suspected local recurrence of rectal carcinoma. Radiol Med 2010; 115(6):906-19.
57. Kim HJ, Park SH, Pickhardt PJ, et al. CT Colonography for Combined Colonic and Extracolonic Surveillance after Curative Resection of Colorectal Cancer. Radiology 2010;257(3):697-704.
58. Choi YJ, Park SH, Lee SS, et al. CT colonography for follow-up after surgery for colorectal cancer. AJR Am J Roentgenol 2007;189(2):283-9.
59. Fletcher JG, Johnson CD, Krueger WR, et al. Contrast-enhanced CT colonography in recurrent colorectal carcinoma: feasibility of simultaneous evaluation for metastatic disease, local recurrence, and metachronous neoplasia in colorectal carcinoma. AJR Am J Roentgenol 2002; 178(2):283-90.
60. You YT, Chang Chien CR, Wang JY, et al. Evaluation of contrast-enhanced computed tomographic colonography in detection of local recurrent colorectal cancer. World J Gastroenterol 2006; 12(1):123-6.
61. Van Rijn JC, Reistma JB, Stoker J, et al. Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review. Am J Gastroenterol 2006;101:343-350.
62. Kim HG, Lee SH, Jeon SR, et al. Clinical significance of the first surveillance colonoscopy after endoscopic early colorectal cancer removal. Hepatogastroenterol 2013;60(125):1047-52.
63. Pangana, TJ, Ledesma EJ, Mittleman A, et al. The use of colonoscopy in the study of synchronous colorectal neoplasms. Cancer 1984;53:356-359.
64. Kronborg O, Hage E, Deichgraeber E. The remaining colon after radical surgery for colorectal cancer. The first three years of a prospective study. Dis Col Rectum 1983;26:172-76.
65. Weber CA, Deveney KE, Pellegrini CA, et al. Routine colonoscopy in the management of colorectal cancer. AM J Surg 1986;152:87-92.
66. Langevin JM, Nivatvongs S. The true incidence of synchronous cancer of the large bowel. A prospective study. Am J Surg 1984;147:330-333.
67. American Cancer Society/US Multisociety Task Force on Colorectal Cancer/ American College of Radiology (ACS/USMSTF/ACR). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58(3):130-60.
68. Wang T, Cui Y, Huang WS, et al. The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study. Gastrointest Endosc 2009;69:609-15.
69. Matsuda A, Kishi T, Musso G, et al. The effect of intraoperative rectal washout on local recurrence after rectal cancer surgery: a meta-analysis. Ann Surg Oncol 2013; 20(3):856-63.
70. Hassan C. Pickhardt PJ, Zullo A, et al. Cost-effectiveness of early colonoscopy surveillance after cancer resection. Dig Liv Dis 2009;41:881-885.
71. Di Cristafaro L, Scarpa M, Angriman I, et al. Cost-effectiveness analysis of postoperative surveillance protocols following radical surgery for colorectal cancer. Acta Chir Belg 2012;122:24-32.
72. Beynon J, Mortensen NJ, Foy DM, et al. The Detection and Evaluation of Locally Recurrent Rectal Cancer with Rectal Endosonography. Dis Colon Rectum 1989;32:509-517.
73. Woodward T, Menke D. Diagnosis of Recurrent Rectal Carcinoma by EUS-guided Fine-needle aspiration. Gastrointest Endosc 2000;51:223-225.
74. Ramirez JM, Mortensen NJ, Takeuchi N, et al. Endoluminal Ultrasonography in the Follow-up of Patients with Rectal Cancer. Br J Surg 1994;81:692-694.
75. Hunerbein M, Totkas S, Moesta KT, Ulmer C, Handke T, Schlag P. The Role of Transrectal Ultrasound-guided Biopsy in the Post-operative Follow-up of Patients with Rectal Cancer. Surgery 2001;129:164-169.
76. DeWitt J, Ghoral S, Kahi C, LeBlanc J, et al. EUS-FNA of Recurrent Postoperative Extraluminal and Metastatic Malignancy. Gastrointest Endosc 2003;58:542-548.
77. Rotondano G, Esposito P, Pellecchia L, Novi A, Romano G. Early Detection of Locally Recurrent Rectal Cancer by Endosonography. Br J Radiology 1997;70:567-571.
78. Hildebrandt U, Feifel G, Schwarz HP, Scherr O. Endorectal Ultrasound: Instrumentation and Clinical Aspects. Int J Colorect Dis 1986;1:203-207.
79. Konkam P, LeBlanc JK. Diagnosis of Recurrent Rectal Cancer Deep into the Vaginal Wall by Transvaginal Endoscopic Ultrasound-guided Fine Needle Aspiration. Endoscopy 2008;40:873-874.
80. Romano G, Esercizio L, Santangelo M, Vallone G, Santangelo ML. Impact of Computed Tomography vs. Intrarectal Ultrasound on the Diagnosis, Resectability, and Prognosis of Locally Recurrent Rectal Cancer. Dis Colon Rectum 1993;36:261-265.
81. Nakajima S. The Efficacy of the EUS for the Detection of Recurrent Disease in the Anastomosis of Colon. Diagn Ther Endosc 2001;7:149-158.
82. Dewhurst C, Rosen MP, Blake MA, et al. ACR Appropriateness Criteria pretreatment staging of colorectal cancer. J Am Coll Radiol 2012;9(11):775-81.
83. Romano G, De Rosa P, Vallone G, Rotondo A, Grassi R, Santangelo ML. Intrarectal Ultrasound and Computed Tomography in the Pre-and Post-operative Assessment of Patients with Rectal Carcinoma. Br J Surg 1985;72:S117-119.
84. Sasaki Y, Niwa Y, Hirooka Y, et al. The Use of Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Investigation of Submucosal and Extrinsic Masses of the Colon and Rectum. Endoscopy 2005;37:154-160.
85. Novell F, Pascual S, Viella P, Trias M. Endorectal Ultrasonography in the Follow-up of Rectal Cancer. Int J Colorect Dis 1997;12:78-81.
86. Hara K, Yamao K, et al. Endoscopic Ultrasonography and Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for the Diagnosis of Lower Digestive Tract Disease. Endoscopy 2003;35:966-969.
87. Hunerbein M, Totkas S, et al. EUS-guided Fine Needle Biopsy: Minimally Invasive Access to Metastatic or Recurrent Cancer. Eur J Ultra 1999;10:151-157.
88. Morken JJ, Baxter NN, Madoff RD, Finne CO. Endorectal Ultrasound-directed Biopsy: a Useful Technique to Detect Local Recurrence of Rectal Cancer. Int J Colorectal Dis 2006;21:258-264.
89. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg. 1994;81:7-19.
90. Jochmans I, Topal B, D'Hoore A, et al. Yield of Routine Imaging after Curative Colorectal Cancer Treatment. Acta Chir Belg, 2008, 108: 88-92.
91. Chen CS, Hsieh MC, Lai CC, et al. Lead time of carcinoembryonic antigen elevation in the postoperative follow up of colorectal cancer did not affect the survival rate after recurrence. Int J Colorectal Dis 2010;(25):567-571.
92. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965;122(3):467-81.
93. Moertel CG, O'Fallon JR, Go VL, et al: The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer 1986; 58:603-610.
94. Tan E, Gouvas N, Nicholls RJ, et al. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol. 2009 Mar;18(1):15-24.
95. Metser U, You J, McSweeney S, et al. Assessment of Tumor Recurrence in Patients With Colorectal Cancer and Elevated Carcinoembryonic Antigen Level: FDG PET/CT Versus Contrast-Enhanced 64-MDCT of the Chest and Abdomen. Am J Roentgenol 2010; 194:766-771.
96. Walker AS, Nelson DW, Fowler JJ, Causey MW, Quade S, Johnson EK, Maykel JA, Steele SR. An evaluation of colonoscopy surveillance guidelines: are we actually adhering to the guidelines? Am J Surg 2013;205(5):618-22.
97. Sisler JJ, Seo B, Katz A, et al. Concordance with ASCCO guidelines after colorectal cancer treatment: a population based analysis. J Oncol Pract 2012;8(4):e69-e79.
98. Salz T, Weinberger M, Ayanian JZ, et al. Variation in the use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res 2010; 10: 256.
99. Søreide K, Træland JH, Stokeland PJ, et al. Adherence to national guidelines for surveillance after curative resection of nonmetastatic colon and rectum cancer: a survey among Norwegian gastrointestinal surgeons. Colorect Dis 2011;14:320-324.
100. Salloum RG, Hornbrook MC, Fishman PA, et al. Adherence to Surveillance Care Guidelines After Breast and Colorectal Cancer Treatment With Curative Intent. Cancer 2012;118:5644-51.
101. Cheung WY, Pond GR, Rother M, et al. Adherence to Surveillance Guidelines After Curative Resection for Stage II/IIIColorectal Cancer. Clin Colorect Canc 2008;7(3):191-196.